Grand Island Regional Medical Center

CLIA Laboratory Citation Details

2
Total Citations
6
Total Deficiencyies
3
Unique D-Tags
CMS Certification Number 28D2175691
Address 3533 Prairieview St, Grand Island, NE, 68803
City Grand Island
State NE
Zip Code68803
Phone(308) 675-5000

Citation History (2 surveys)

Survey - June 14, 2023

Survey Type: Standard

Survey Event ID: 05S211

Deficiency Tags: D2000 D5217 D2000 D5217

Summary:

Summary Statement of Deficiencies D2000 ENROLLMENT AND TESTING OF SAMPLES CFR(s): 493.801 Each laboratory must enroll in a proficiency testing (PT) program that meets the criteria in subpart I of this part and is approved by HHS. The laboratory must enroll in an approved program or programs for each of the specialties and subspecialties for which it seeks certification. The laboratory must test the samples in the same manner as patients' specimens. For laboratories subject to 42 CFR part 493 published on March 14, 1990 (55 FR 9538) prior to September 1, 1992, the rules of this subpart are effective on September 1, 1992. For all other laboratories, the rules of this subpart are effective January 1, 1994. This CONDITION is not met as evidenced by: Based on review of the laboratory's list of tests performed, 2022 proficiency testing records, 2023 proficiency testing records, interview with the technical consultant (TC) #1, and technical consultant (TC) #2, the laboratory failed to enroll in an approved proficiency testing program for immunoglobulin IgA, immunoglobulin IgG, and immunoglobulin IgM. Findings are: 1. Review of the laboratory's list of tests revealed the laboratory performs testing for immunoglobulin IgA, immunoglobulin IgG, and immunoglobulin IgM. 2. Review of the laboratory's 2022 proficiency testing and 2023 proficiency testing revealed the laboratory failed to enroll in an approved program for immunoglobulin IgA, immunoglobulin IgG, and immunoglobulin IgM. 3. Interview with TC #1 and TC #2 on June 14, 2023 at 3:02 PM confirmed the laboratory did not enroll in an approved program for for immunoglobulin IgA, immunoglobulin IgG, and immunoglobulin IgM. 4. Interview with TC #1 and TC #2 on June 14, 2023 at 3:02 PM revealed the laboratory performed 211 immunoglobulin IgA tests, 246 immunoglobulin IgG tests, and 214 immunoglobulin IgM tests . D5217 EVALUATION OF PROFICIENCY TESTING PERFORMANCE CFR(s): 493.1236(c)(1) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- At least twice annually, the laboratory must verify the accuracy of any test or procedure it performs that is not included in subpart I of this part. This STANDARD is not met as evidenced by: Based on review of the laboratory's list of tests performed, interview with the technical consultant (TC) #1, and technical consultant (TC) #2, the laboratory failed to have a system of verifying the accuracy of testing for the following tests: hemoglobin A1c, haptoglobin, urine sodium, urine chloride, and urine potassium. Findings are: 1. Review of the laboratory's list of tests performed revealed the laboratory performs testing for hemoglobin A1c, haptoglobin, urine sodium, urine chloride, and urine potassium. 2. Interview with TC #1 and TC #2 on June 14, 2023 at 3:02 PM confirmed the laboratory reported 2918 hemoglobin A1c tests, 118 haptoglobin tests, 216 urine sodium tests, nine urine chloride tests, and ten urine chloride tests. 3. Interview with TC #1 and TC #2 on June 14, 2023 at 3:02 PM confirmed the laboratory did not perform accuracy verification at least twice annually for hemoglobin A1c, haptoglobin, urine sodium, urine chloride, and urine potassium. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - October 1, 2021

Survey Type: Standard

Survey Event ID: OOFH11

Deficiency Tags: D5449 D5449

Summary:

Summary Statement of Deficiencies D5449 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(ii)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each qualitative procedure, include a negative and positive control material; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on review of quality control logs and an interview with the technical supervisor the laboratory failed to perform controls each day of testing for the Amnisure testing system for the detection of placental alpha microglobulin-1 (PAMG-1). Findings are: 1. Review of quality control logs for Amnisure testing revealed quality control testing was performed monthly and with every new shipment/new lot. 2. Interview with the technical supervisor on 9/30/2021 at 4:00 PM confirmed controls were run monthly and with every new shipment/new lot. Technical supervisor confirmed 24 patients were tested for PAMG-1 since testing started in July 2021. 3. Interview with the technical supervisor on 9/30/2021 at 4:00 PM confirmed the laboratory had not implemented an individual quality control plan for the Amnisure test. Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 1 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access